跳至主要内容
临床试验/NCT00249743
NCT00249743已完成1 期

NIH-NIA SBIR Phase I/II Study: Clinical Evaluation of a Device to Reduce Patient Falls

NOCwatch International2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2004年12月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
50
试验地点
2
主要终点
Falls and fall-related injuries.

研究概览

简要总结

Falls are a public health problem of significant social and economic significance. No primary intervention devices have been shown to be effective in reducing falls and associated injuries. The objective of this study was to determine whether the new wireless FallSaver device reduces falls and fall-related injuries in elderly skilled nursing facility (SNF) residents. A randomized, prospective, open-label, cross-over study was conducted over a six-month period. The FallSaver device reduced the frequency of falls by 50% and fall-related injuries by 82% in 43 elderly at-risk SNF residents studied over 4,222 patient-days. The device and associated patch enclosure was well tolerated and devoid of serious problems. Significant cost savings and fewer reductions in quality of life are possible if fall-related injuries can be reduced.

详细描述

OBJECTIVE. No existing devices have proven effective in preventing falls in at-risk individuals. The objective of this study was to determine whether the FallSaver device reduces falls and fall-related injuries in elderly skilled nursing facility (SNF) residents.

DESIGN. This was a randomized, prospective, open-label, cross-over study conducted over a six-month period.

SETTING: The study took place in a 100-bed State Veterans SNF in Washington State.

PARTICIPANTS. Forty-four subjects with anticipated institutional stays of at least 120 days participated in the study. The subjects' mean age was 82.2 + 7.1 years and all were rated high fall risks using the Morse scale.

INTERVENTION Subjects were randomly assigned to the FallSaver device or no device (Observation) for 60 days. Following the end of the 60-day period subjects were crossed over to the opposite treatment. The device, enclosed in an adhesive patch, was applied to the subject's thigh.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
None

入排标准

年龄范围
0 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Residents of a skilled nursing facility. An anticipated institutional stay of at least 120 days. Individuals with a high risk of falling according to the Morse scale (a score of 55+).

排除标准

  • Individuals who were allowed to self-ambulate. Individuals with a history of adverse reactions to medical adhesives. Individuals with a history or presence of significant skin breakdown on the legs.

结局指标

主要结局

Falls and fall-related injuries.

次要结局

  • Falls resulting from documented attempts to stand or ambulate without assistance.
  • Skin tolerance to the adhesive.
  • Compliance.

研究者

发起方
NOCwatch International
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验

进行中(未招募)
不适用
A multicenter phase II study to evaluate safety and efficacy of glutadon once weekly (GDO) in patients with metastatic colorectal cancer resistant or intolerable to approved chemo- and molecular-targeted therapies
EUCTR2009-017871-13-PLew Medical Enzymes AG
进行中(未招募)
不适用
Etude multicentrique de phase 2 évaluant la tolérance et l’efficacité du BKM120 en monothérapie dans le cancer de l’endomètre métastatique d’emblée ou en rechute après une première ligne, chez des patientes ne pouvant être traitées avec une chirurgie locale et/ou une radiothérapie.initial or recurrent metastatic endometrial cancer after first line therapy in patients who cannot undergo local surgery and/or radiotherapy.
EUCTR2011-002576-16-FRARCAGY
已完成
不适用
A multicenter phase II study assessed safety and efficacy of asunaprevir and daclatasvir in patients with chronic hepatitis C virus genotype 1 infection and end-stage renal disease requiring hemodialysisChronic hepatitis C with end-stage renal disease requiring hemodialysis
JPRN-UMIN000015882Saga Study Group of Liver Diseases25
进行中(未招募)
2 期
A multi center, phase 2 study to Evaluate safety and efficacy of total Neoadjuvant treatment of long courSE radiotherapy followed by cheMotherapy, capecitaBine combined with oxaliplatin (CAPOX) for Locally advanced rEctal cancer(ENSEMBLE-2)
JPRN-jRCTs071210143KAGAWA Yoshinori27
进行中(未招募)
不适用
A Phase IIa, Safety and Preliminary Effects Study of WST11 (Stakel®)-Mediated Vascular-Targeted Photodynamic (VTP) Therapy in Subjects with Choroidal Neovasularization (CNV) Associated with Age-Related Macular Degeneration (AMD)
EUCTR2009-017435-18-FRSteba Biotech S.A.18